Until now, the gold standard for clinically diagnosing RA patients has been based on self-reported symptoms, assessment of swollen and tender joints, quantification of levels of rheumatoid factor, anti-CCP auto-antibodies against citrullinated filaggrin peptides, as well as imaging techniques, such as X-ray of the joints. This evidence concerns the gene FLG and rheumatoid arthritis.